Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MAX HEALTHCARE INSTITUTE LTD.

NSE : MAXHEALTHBSE : 543220ISIN CODE : INE027H01010Industry : Hospital & Healthcare ServicesHouse : Max

BSE1157.00-16.35 (-1.39 %)

PREV CLOSE ( ) 1173.35

OPEN PRICE ( ) 1173.50

BID PRICE (QTY) 1156.50 (19)

OFFER PRICE (QTY) 1156.80 (17)

VOLUME 8317

TODAY'S LOW / HIGH ( )1156.35 1173.50

52 WK LOW / HIGH ( )889 1314.3

NSE1158.10-15.3 (-1.3 %)

PREV CLOSE( ) 1173.40

OPEN PRICE ( ) 1170.00

BID PRICE (QTY) 1158.00 (467)

OFFER PRICE (QTY) 1158.10 (27)

VOLUME 421575

TODAY'S LOW / HIGH( ) 1156.00 1176.40

52 WK LOW / HIGH ( )888.9 1314.3

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

14063.70

13653.20

10637.20

7389.00

-686.50

Adjustment

4982.90

1848.50

2258.40

2412.20

5047.40

Changes In working Capital

-1244.10

-1592.20

1556.90

-1305.40

-3762.50

Cash Flow after changes in Working Capital

17802.50

13909.50

14452.50

8495.80

598.40

Cash Flow from Operating Activities

14593.10

11216.70

12841.30

7405.20

1178.60

Cash Flow from Investing Activities

-16317.40

-12854.50

-1023.20

-7638.00

-730.00

Cash Flow from Financing Activities

-1638.00

-2637.40

-2885.60

-2941.70

1913.30

Net Cash Inflow / Outflow

-3362.30

-4275.20

8932.50

-3174.50

2361.90

Opening Cash & Cash Equivalents

9798.40

13743.30

4809.70

6265.90

1110.10

Cash & Cash Equivalent on Amalgamation / Take over / Merger

2793.90

Cash & Cash Equivalent of Subsidiaries under liquidations

175.10

347.20

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

1.20

-18.20

1.10

Closing Cash & Cash Equivalent

6612.40

9797.10

13743.30

3091.40

6265.90